+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatitis B Drug"

From
Chronic Hepatitis B Market Report 2026 - Product Thumbnail Image

Chronic Hepatitis B Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Chronic Hepatitis B (CHB): Epidemiology Forecast to 2034 - Product Thumbnail Image

Chronic Hepatitis B (CHB): Epidemiology Forecast to 2034

  • Report
  • August 2025
  • 54 Pages
  • Global
From
From
Liver Diseases Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Liver Diseases Therapeutics Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 195 Pages
  • Global
From
Antiviral Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antiviral Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 192 Pages
  • Global
From
Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035 - Product Thumbnail Image

Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035

  • Report
  • March 2025
  • 245 Pages
  • Global
From
From
From
Hepatitis B - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis B - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
VEMLIDY Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

VEMLIDY Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
From
Entecavir Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Entecavir Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
Loading Indicator

The Hepatitis B Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat the hepatitis B virus, a virus that can cause serious liver damage. These drugs are used to reduce the amount of virus in the body, reduce the risk of liver damage, and improve overall health. Common drugs used to treat hepatitis B include interferon, nucleoside analogues, and protease inhibitors. The Hepatitis B Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Gilead Sciences, Merck & Co., AbbVie, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more